03271nam 2200661Ia 450 991078145060332120230725053809.00-19-174025-X0-19-960737-01-283-34833-097866133483330-19-157581-X(CKB)2550000000064626(EBL)797725(OCoLC)763157034(SSID)ssj0000555589(PQKBManifestationID)12244098(PQKBTitleCode)TC0000555589(PQKBWorkID)10519626(PQKB)10355720(MiAaPQ)EBC797725(StDuBDS)EDZ0000091506(Au-PeEL)EBL797725(CaPaEBR)ebr10511371(CaONFJC)MIL334833(MiAaPQ)EBC7039287(Au-PeEL)EBL7039287(EXLCZ)99255000000006462620100924d2010 uy 0engur|n|---|||||txtccrSystemic treatment of prostate cancer[electronic resource] /edited by Alan HorwichOxford ;New York Oxford University Press20101 online resource (102 p.)Oxford oncology libraryDescription based upon print version of record.0-19-956142-7 Includes bibliographical references and index.Contents; Preface; Symbols and abbreviations; Contributors; 1 Biological principles of hormone therapy; 2 PSA as a marker of progression and response in advanced prostate cancer; 3 Neo-adjuvant and adjuvant hormone therapy for high-risk localized prostate cancer; 4 Systemic treatment of recurrence after local therapies; 5 First-line hormone therapy for metastatic prostate cancer; 6 Second- and third-line hormone therapies; 7 Chemotherapy for metastatic prostate cancer; 8 The role of bisphosphonates in the systemic treatment of prostate cancer; 9 Systemic isotope therapy of bone metastasis10 Biological targets and new drug development for prostate cancerIndex; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; R; S; T; U; V; W; ZProstate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is central to management. Hormone ablation has long been the mainstay ofendocrine therapy in this group of patients, though anti-androgens, oestrogens and corticosteroids can also cause rOxford oncology library.ProstateCancerDiagnosisProstateCancerTreatmentProstateCancerDiagnosis.ProstateCancerTreatment.616.9946306Horwich Alan1493544MiAaPQMiAaPQMiAaPQBOOK9910781450603321Systemic treatment of prostate cancer3716555UNINA